Insulin Delivery Devices Market to Rear Excessive Growth During 2020-2026

1
Insulin Delivery Devices Market To Reach USD
27.61 Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Prevalence of diabetes, product launches and
continuous research and development key factors
contributing to high CAGR of Insulin Delivery
Devices during forecast period. Market Size
USD 13.39 Billion in 2018, Market Growth - CAGR
of 9.3, Market Trends Product launches and
research for novel Insulin Delivery Devices
3
Our Approach
Market Summary

• According to the current analysis of Reports and
  Data, the global Insulin Delivery Devices market
  was valued at USD 13.39 Billion in 2018 and is
  expected to reach USD 27.61 Billion by year 2026,
  at a CAGR of 9.3. Insulin is a naturally
  occurring hormone that is responsible for
  allowing glucose in the blood to enter the blood
  stream, providing them with energy to function.
  Being essential to life, a lack of its secretion
  or improper secretion of insulin. A lack of
  effective insulin plays a key role in the
  development of diabetes. Thus, people with
  diabetes have to externally inject insulin in
  order to sustain themselves. With the changes in
  the lifestyle of the people there has been a
  spike in the number of cases of diabetes and
  therefore there has been a rise in the demand for
  insulin delivery devices. Insulin delivery
  devices are very useful for people suffering from
  type I diabetes. There are various types of
  delivery devices and the choice of the devices
  depend on the patients. The continuous research
  and development in this field and launch of novel
  devices has propelled the market. For instance,
  the announcement of the approval of interoperable
  pumps has aroused interest in the market. In
  addition the proposed launch of smart insulin
  pens has further sparked interest among the
  people for this market. Such factors increase the
  demand for the devices.
• The key players in the market include Sanofi
  Diabetes, Nova Nordisk, Omnipod Insulin
  Management, Eli Lilly and Company, Gerresheimer,
  Johnson and Johnson, Becton Dickinson, Tandem
  Diabetes Care Inc. and Medtronic Plc.
• To Get Sample Copy of Report visit
  https//www.reportsanddata.com/sample-enquiry-form
  /1748

4
Our Approach
Market Summary

• For the purpose of this report, Reports and Data
  has segmented the Insulin Delivery Devices market
  on the basis of type, distribution channel, end
  use, and region
• Type (Revenue, USD Million 20162026)
• Insulin Syringe
• Insulin Pens
• Disposable
• Reusable
• Insulin Jet Injectors
• Insulin Pumps
• Tethered
• Patch
• Insulin Needles
• Insulin Inhalers
• External Insulin
• Implantable Insulin

5
Our Approach
Market Summary

• Distribution Channels (Revenue, USD Million
  20162026)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• End Use (Revenue, USD Million 20162026)
• Hospitals
• Clinics
• Ambulatory Care Centers
• Homecare
• Do you have questions about the Report or want to
  inquire about a Discount? Ask our Expert
  https//www.reportsanddata.com/discount-enquiry-fo
  rm/1748

6
Our Approach
Market Summary

• Further key findings from the report suggest
• Medtronics MiniMed 670G System has been a
  milestone in this market. It was recently
  launched, making delivery of insulin simpler and
  easier.
• Insulin pens are expected to grow at a rate of
  9.2. The expected launch of smart insulin pens
  in the year 2019 has sparked further interest in
  this market. Insulin pens have been proven to be
  easier at application and accessible. Thus, they
  dominate the market with a share of 50.8.
• Insulin Pumps are seen to be the fastest growing
  devices with the rising awareness. They are
  expected to register a growth rate of 11.2.
• With the advanced devices in the market, taking
  insulin at home has been made possible. Thus, the
  rising preference towards homecare has made it
  dominate the market. It registers a market share
  of 68 and continues to grow at a rate of 9.5.
• The availability of financial assistance
  facilities and the strong government support and
  initiatives to make insulin delivery devices and
  medications affordable has been a big boost to
  the market.
• North America records the highest number of cases
  of diabetes. The changes in lifestyle, improper
  dietary habits and lack of exercise have been the
  key factors responsible for the increased number
  of cases. Thus, North America dominates the
  market by holding more than 50 market shares.
• Read More _at_ https//www.reportsanddata.com/report-
  detail/insulin-delivery-devices-market

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com